国外 1. 大摩：沃什治下的美联储变化将先体现在缩表上 摩根士丹利在一份报告中表示，在沃什执掌的美联储之下，任何实质性的变化更可能通过资产负债表政 策而非利率来逐步显现。缩减美联储资产负债表规模意味着降低银行对准备金的需求，而这一过程需要 时间，并且还需要对监管框架作出调整。摩根士丹利补充称："在其他条件不变的情况下，一个在对外 沟通和资产负债表规模上都采取更小'存在感'的美联储，应会推动收益率曲线趋于陡峭。" 2. 摩通私银：金价属健康技术性回调、仓位远未拥挤，年底看6150美元 国际金价大幅回调，摩根大通私人银行亚洲宏观策略主管唐雨旋认为，这次金价属健康的技术性回调， 因此前升势带有一定非理性成分，而此次调整有效消化了部分投机性仓位。值得注意的是，金价仅回到 两周前的水平，1月份仍录得13%的升幅。以往经验作参考，去年10月由4400美元回落至3900美元后， 曾短暂盘整，随后突破向上，至12月已收复并重上前高，故该行对黄金的基本面看法并无改变。唐雨旋 称，根据2025年数据，新兴市场央行的黄金储备占比仍处于低双位数，中国亦仅在高个位数，追赶空间 明显，同时ETF持仓亦仍低于2022至2023年的高位，而 ...

Summary of Key Points from Conference Call Records Industry and Company Overview - The conference call discusses the global economic landscape, focusing on the implications of U.S. monetary policy, U.S.-China relations, and the technology sector's development in 2026 [1][2][4]. Core Insights and Arguments U.S. Monetary Policy - The Federal Reserve is expected to maintain a passive easing policy, with potential impacts on liquidity influenced by Trump's announcement of the next Fed chair, which could benefit tech stocks but with limited sustainability [1][2]. - A key focus is on the timing of the Fed's shift to active easing, which historically has been favorable for U.S. equities [3]. U.S.-China Relations - 2026 is highlighted as a pivotal year for U.S.-China relations, with significant events such as Trump's potential visit to China and the need for a trade agreement by September to gain support from key voter demographics [5][6]. - The Chinese government is likely to implement policies to guide long-term capital into the market and support technological development in response to U.S. competition [4]. Domestic Policy Directions - China's domestic policies will become more proactive in addressing international competition, focusing on developing new productive forces and reducing reliance on high technology [7][11]. - The emphasis will be on enhancing the value of domestic industries and addressing the challenges posed by U.S. policies [11][12]. Investment Opportunities - Key investment opportunities in 2026 include sectors related to AI applications, AR technology, humanoid robotics, consumer electronics, and innovative pharmaceuticals [13]. - The focus on new energy supply chains, including critical materials like lithium and silicon, is emphasized as a strategic area for investment [12][37]. Risks and Market Dynamics - The Nasdaq's current valuation is noted to be significantly lower than during the Obama administration, despite higher ROE, indicating potential for recovery as the Fed shifts to active easing [3]. - The technology sector is experiencing volatility not primarily due to AI issues but rather due to market share shifts among companies, which could lead to increased investment and technological advancement in the long term [3]. Other Important but Potentially Overlooked Content Economic Indicators - The Shanghai Composite Index and the RMB/USD exchange rate are identified as critical indicators for monitoring China's economic health and policy effectiveness [8]. - The anticipated annual increase in the Shanghai Composite Index is projected to be between 10% and 20%, with a focus on maintaining a low volatility environment [8]. Housing Market Outlook - The housing market is expected to remain in a correction phase, with rental yields significantly lower than mortgage rates, making renting more attractive than buying [16]. Consumer and Fiscal Policies - China's consumer and fiscal policies are designed to ensure social stability amid geopolitical tensions, with limited scope for aggressive consumer spending initiatives [14][15]. Structural Changes in the Economy - The ongoing structural changes in China's economy, particularly in the real estate sector, are leading to a decline in disposable income growth and consumer sentiment, impacting overall economic stability [23]. Strategic Focus Areas - The conference highlights the importance of focusing on industries that can enhance China's competitive edge in global markets, particularly in technology and energy sectors [27][34]. This summary encapsulates the key points discussed in the conference call, providing insights into the strategic directions and investment opportunities within the context of the evolving global economic landscape.

Group 1 - The Hong Kong innovative drug sector experienced a strong performance, with companies like 3SBio and BeiGene rising by 6%, and others like InnoCare and CanSino Biologics increasing by 4.36% and 3.72% respectively, contributing to a 2% rise in the Hang Seng Pharmaceutical ETF [1] - BeiGene reported a total revenue of $1.4 billion for Q3, marking a 41% year-on-year increase and achieving a historical high for the same period, with a GAAP net profit of $125 million, reversing previous losses [1] - The negotiation for the 2025 National Basic Medical Insurance Drug List and the pricing discussions for innovative drugs in commercial insurance were completed last week, with expectations of active business development transactions in November and December, coinciding with major industry conferences [1] Group 2 - The Hong Kong Central Enterprise Dividend ETF saw a rise of over 1%, accumulating an 11% increase since September 26, indicating renewed investor interest in high-dividend assets as year-end approaches [1] - The Central Enterprise Dividend ETF includes major stocks such as COSCO Shipping Holdings, Orient Overseas International, CITIC Bank, China Construction Bank, China National Offshore Oil Corporation, and PetroChina [2] - The Hang Seng Pharmaceutical ETF, representing the global pharmaceutical industry chain, increased by 2.85%, with top-weighted stocks including BeiGene, WuXi Biologics, InnoCare, China National Pharmaceutical Group, and 3SBio [2]

Core Viewpoint - The A-share and Hong Kong stock markets experienced fluctuations in October, with Hong Kong showing strong overall profitability and low valuations despite recent gains [1][2][4]. A-share Market Summary - The A-share market showed mixed performance in October, with the Shanghai Composite Index rising by 2.7% while the Sci-Tech Innovation 50 Index fell by 1.6% [2]. - Various sectors exhibited significant performance divergence, with coal, telecommunications, and banking sectors performing well due to market sentiment and profit-taking [2][3]. - Positive factors such as the approval of the 15th Five-Year Plan and ongoing US-China trade negotiations are expected to bolster market confidence [3]. Hong Kong Market Summary - The Hong Kong stock market faced a pullback in October due to increased overseas uncertainties and a decline in domestic risk appetite, with major indices showing mixed results [2]. - Despite recent increases, the overall valuation of the Hong Kong market remains low, indicating a favorable long-term investment opportunity [1][4]. - The market is expected to continue a volatile upward trend, supported by the ongoing development of the AI industry and the commencement of the Federal Reserve's interest rate cuts [4]. Industry Configuration - Mid-term focus should be on the TMT (Technology, Media, Telecommunications) and advanced manufacturing sectors, with a shift to high-dividend and consumer sectors during market fluctuations [3][4]. - A "barbell" strategy is recommended, emphasizing both technology growth and high-dividend stocks, particularly in sectors like telecommunications, utilities, and banking [4].

Group 1 - The Hong Kong stock market has experienced greater volatility compared to the A-share market in recent years, with 2020 marking a significant turning point [1] - Prior to 2020, the Hong Kong and US stock markets were positively correlated, but this changed post-2020 due to high valuations of growth and consumer stocks, regulatory challenges for internet companies, continuous foreign capital outflow, and risks associated with leading real estate companies [1] - Recent trends indicate a reversal in these factors, with a surge in IPO financing, leading companies' stock prices in Hong Kong surpassing those in A-shares, and a consistent increase in net purchases of Hong Kong stocks by southbound funds [1] Group 2 - Over the past year, sectors such as technology, dividends, and pharmaceuticals in the Hong Kong market have significantly outperformed the A-share market, with the level of stock holdings in Hong Kong becoming a critical factor for investment success [2] - Hong Kong internet companies have notably benefited from advancements in artificial intelligence, while high-dividend stocks have thrived in a low-interest-rate environment [2] - The innovative pharmaceutical sector, which faced substantial declines in previous years, is now experiencing explosive growth, driven by increased overseas business and improved domestic healthcare policies [2] Group 3 - Despite the recent rebound in the Hong Kong market, major indices are still considered to be undervalued compared to other global markets, indicating potential for further price increases [2] - The overall profitability of companies in the Hong Kong market has improved significantly, suggesting a need for re-evaluation of Chinese assets, starting with Hong Kong stocks [2] - Leading companies in the Hong Kong market are viewed as having better liquidity and higher potential returns, with capabilities to operate globally across various industries [2] Group 4 - Over the past decade, many industries in China have seen increased concentration, and the next five to ten years may witness a widening gap between industry leaders and followers [3] - Investment strategies focused on long-term holding and selecting understandable companies align closely with value investing principles [3] - The essence of successful investing is to "choose wisely, buy right, and hold on," with the holding phase being the most challenging and critical [3]

Market Performance - On July 1, the major stock indices in Shanghai and Shenzhen opened mixed, with the Shanghai Composite Index slightly higher and the Shenzhen Component and ChiNext Index also opening with minor gains. The Shanghai Composite Index showed a fluctuating upward trend throughout the day, closing at 3457.75 points, up 0.39%, marking a new year-to-date closing high [1] - The Shenzhen Component Index closed at 10476.29 points, up 0.11%, while the ChiNext Index closed at 2147.92 points, down 0.24%. The total trading volume for the Shanghai market was approximately 553.6 billion yuan, and for the Shenzhen market, it was about 912.5 billion yuan [1] Sector Performance - The pharmaceutical sector led the gains, with significant increases in various sub-sectors such as immunotherapy, innovative drugs, recombinant proteins, generic drugs, weight loss drugs, hepatitis concepts, and hair medical treatments. Other sectors that saw notable increases included shipbuilding, industrial gases, photolithography machines, banking, and superconducting concepts [1] - Conversely, digital currency stocks experienced significant declines, along with substantial adjustments in sectors like electronic identification, cross-border payments, and Web3 concepts [1] Institutional Insights - According to institutional views, the market is expected to experience fluctuations, with a historical 60% probability of the Shanghai Composite Index rising in July. Investors are advised to focus on defensive sectors in the early part of the month and shift attention to mid-year performance reports and policy movements later on. Key sectors to watch include technology (semiconductors, AI), military industry, and high-growth areas in mid-year reports [2] - Another institution emphasized the importance of focusing on performance-driven sectors and stable assets as the earnings season approaches, with expected growth in industries such as steel, computers, and defense [2] Policy Developments - The National Healthcare Security Administration announced that a draft for the commercial insurance innovative drug directory and the medical insurance directory will be released soon. This initiative aims to streamline the application process for companies and ensure that both directories are aligned in their adjustments [4] - The State-owned Assets Supervision and Administration Commission is accelerating the development of the new energy vehicle industry, focusing on enhancing the capabilities of young talents in intelligent development and digital marketing [5]

Group 1 - The macro background for the A-share adjustment in Q2 includes a natural decline in Chinese exports and increased tariff threats from the US, leading to amplified macroeconomic expectations and a decrease in risk appetite [1][2] - The direct reason for the short-term market adjustment is the approaching "April Decision" period, which includes the verification of annual and quarterly reports, as well as economic data from China and the implementation of US tariffs [1][2] - The adjustment pressure from the April verification period is considered limited, with expectations for domestic AI computing power to potentially show strong differentiation and growth [1][3] Group 2 - The macroeconomic issues persisting into Q2 include the natural decline in Chinese exports and the potential for further US tariff threats, which may lead to a weak and volatile A-share market [2][4] - The narrative of the current technology adjustment is similar to the Nasdaq adjustment from July to October 2023, characterized by slow application realization and concerns over excessive investment in computing power [2][3] - The adjustment in domestic AI computing power is seen as a shorter phase compared to the US, as the industry is still in a stage of basic breakthroughs with insufficient application layer development [3][4] Group 3 - Defensive thinking is favored in Q2 2025, with a focus on high dividend relative returns and the strengthening of pricing power for short-term allocation funds [4][5] - The technology structural bull market is expected to continue into 2025, with investment opportunities identified in domestic AI computing power and applications, embodied intelligence, and low-altitude economy [4][5] - The valuation advantage of Hong Kong stocks over A-shares is highlighted, particularly in the context of insurance capital's increasing influence on high dividend assets [5]

Core Viewpoint - The article emphasizes the upcoming "April Decision" as a critical period for economic and A-share performance verification, highlighting concerns over potential new tariffs from the U.S. and a cautious narrative surrounding AI advancements [1][2]. Short-term Adjustment Triggers - The "April Decision" window is approaching, with the first quarter reports for the economy and A-shares set to validate market fundamentals. China's export growth is expected to naturally decline, and the impact of tariffs has yet to be fully realized. The effectiveness of fiscal policies remains to be seen [2][3]. - Concerns are rising regarding the U.S. potentially imposing additional tariffs on China, which could exacerbate economic volatility and suppress risk appetite in the market [2][3]. - A temporary lull in AI advancements is noted, with cautious narratives emerging about the slow progress of large models and the lack of blockbuster applications. This has led to a phase of adjustment in the tech sector [2][3]. Key Influencing Factors of the "April Decision" - The performance verification period is crucial, with expectations for revenue and net profit improvements in the domestic AI computing power industry due to high capital expenditures from internet giants and operators. However, the market's pessimistic expectations for performance reports are unlikely to lead to significant adjustments [3][4]. - The anticipated economic verification in April is expected to have limited marginal impact on the market, as the current expectations for cyclical improvement are low [4]. - The release of a U.S. tariff report on April 1 and subsequent actions may limit the significance of the "bad news" effect, with ongoing concerns about potential tariff increases affecting market sentiment [4][5]. AI Industry Trends - The AI industry is seen as a process where large models and computing power mutually promote breakthroughs in applications. The current phase is characterized by waiting for blockbuster applications, with market adjustments expected to be limited in scope and duration [5][6]. - The market is currently focused on the potential for application innovations, with the possibility of new highs in technology following the realization of these applications [6][7]. Defensive Investment Strategy - In the second quarter of 2025, a defensive investment mindset is favored, with a focus on high-dividend assets that offer both absolute and relative returns. The technology sector is expected to maintain its upward trend, with continued interest in domestic AI computing power and applications, embodied intelligence, and low-altitude economy investment opportunities [6][7]. - The shift of Hong Kong stocks towards A-share characteristics is noted, with high-dividend stocks and internet companies in Hong Kong expected to perform well in their respective styles [7].